Related references
Note: Only part of the references are listed.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
Philipp Grosse-Gehling et al.
JOURNAL OF PATHOLOGY (2013)
Tumor-Initiating Cells in Childhood Neuroblastoma-Letter
Sofie Mohlin et al.
CANCER RESEARCH (2012)
Direct Reprogramming of Mouse and Human Fibroblasts into Multipotent Neural Stem Cells with a Single Factor
Karen L. Ring et al.
CELL STEM CELL (2012)
Genotype analysis of tumor-initiating cells expressing CD133 in neuroblastoma
Sonia Cournoyer et al.
GENES CHROMOSOMES & CANCER (2012)
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
Herve Sartelet et al.
HISTOPATHOLOGY (2012)
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat
Till Milde et al.
ACTA NEUROPATHOLOGICA (2011)
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux
Michelle J. Henderson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
H. Takenobu et al.
ONCOGENE (2011)
T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications
Frederic Lluis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CD133 expression in chemo-resistant Ewing sarcoma cells
Xiaohua Jiang et al.
BMC CANCER (2010)
Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate
Bin Zhang et al.
CANCER CELL (2010)
Stem-like Cancer Cells Are Inducible by Increasing Genomic Instability in Cancer Cells
Yi Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Impact of Histone Deacetylase Inhibitors SAHA and MS-275 on DNA Repair Pathways in Human Mesenchymal Stem Cells
Giovanni Di Bernardo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
Anna Maria Calcagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Resistance of Stem-Like Cells From Neuroblastoma Cell Lines to Commonly Used Chemotherapeutic Agents
Sharada D. Vangipuram et al.
PEDIATRIC BLOOD & CANCER (2010)
Comparison of the Side Populations in Pretreatment and Postrelapse Neuroblastoma Cell Lines
Thomas C. Newton et al.
TRANSLATIONAL ONCOLOGY (2010)
Histone deacetylase inhibitors as anti-neoplastic agents
Nicolas Batty et al.
CANCER LETTERS (2009)
Identification of Cancer Stem Cells in Ewing's Sarcoma
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
Nikolaos A. Dallas et al.
CANCER RESEARCH (2009)
Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Roger Besancon et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Role for Notch Signaling in Salivary Acinar Cell Growth and Differentiation
Howard Dang et al.
DEVELOPMENTAL DYNAMICS (2009)
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Michael Dean
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
Yonatan Y. Mahller et al.
PLOS ONE (2009)
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Giulia Bertolini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
lumi:: a pipeline for processing Illumina microarray
Pan Du et al.
BIOINFORMATICS (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Metastatic cancer stem cells - A new target for anti-cancer therapy?
Patrick C. Hermann et al.
CELL CYCLE (2008)
Wnt signaling promotes reprogramming of somatic cells to pluripotency
Alexander Marson et al.
CELL STEM CELL (2008)
Quantitative Mass Spectrometry Identifies Drug Targets in Cancer Stem Cell-Containing Side Population
Sebastian C. J. Steiniger et al.
STEM CELLS (2008)
Identification and expansion of the tumorigenic lung cancer stem cell population
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2008)
Brca1 breast tumors contain distinct CD44(+)/CD24(-) and CD133(+) cells with cancer stem cell characteristics
Mollie H. Wright et al.
BREAST CANCER RESEARCH (2008)
ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells
Juan Wang et al.
CANCER RESEARCH (2007)
Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell
Loen M. Hansford et al.
CANCER RESEARCH (2007)
Histone deacetylase 1 gene expression and Sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide
Nino Keshelava et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Atsushi Suetsugi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties
Tetsuhiro Chiba et al.
HEPATOLOGY (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
A distinct side population of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
'Side Population' cells in adult mouse testis express Bcrp1 gene and are enriched in spermatogonia and germinal stem cells
B Lassalle et al.
DEVELOPMENT (2004)
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
BM Bolstad et al.
BIOINFORMATICS (2003)
Functional and molecular characterisation of mammary side population cells (vol 5, pg R1, 2003)
AJ Alvi et al.
BREAST CANCER RESEARCH (2003)
Stemness: Transcriptional profiling of embryonic and adult stem cells
M Ramalho-Santos et al.
SCIENCE (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
A genetic analysis of neural progenitor differentiation
DH Geschwind et al.
NEURON (2001)
Share Paper
